Add this result to my export selection Human medicines: highlights of 2020 Source: European Medicines Agency - EMA (Remove filter) Published by European Medicines Agency, 21 January 2021 The EMA has published an overview of its key recommendations in 2020 on the authorisation and safety monitoring of medicines for human use. 97 medicines were recommended for marketing authorisation. Read Summary Type: Medicines Current Awareness (Add filter)
Add this result to my export selection European Medicines Agency (EMA) highlights key role of healthcare professionals (HCPs) in fostering confidence in COVID-19 vaccines Source: European Medicines Agency - EMA (Remove filter) Published by European Medicines Agency, 19 January 2021 EMA endorsed this joint statement by the International Coalition of Medicines Regulatory Authorities, in order to support HCPs when speaking to and reassuring the public that the regulatory processes... Read Summary Type: Medicines Current Awareness (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Dificlir (updated) Source: European Medicines Agency - EMA (Remove filter) 18 January 2021 Dificlir { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated) Source: European Medicines Agency - EMA (Remove filter) 18 January 2021 Clopidogrel TAD { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated) Source: European Medicines Agency - EMA (Remove filter) 18 January 2021 Bortezomib Fresenius Kabi { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Toujeo (previously Optisulin) (updated) Source: European Medicines Agency - EMA (Remove filter) 15 January 2021 Toujeo (previously Optisulin) { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Tresiba (updated) Source: European Medicines Agency - EMA (Remove filter) 15 January 2021 Tresiba { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Brintellix (updated) Source: European Medicines Agency - EMA (Remove filter) 15 January 2021 Brintellix { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Busulfan Fresenius Kabi (updated) Source: European Medicines Agency - EMA (Remove filter) 15 January 2021 Busulfan Fresenius Kabi { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" } Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): INOmax (updated) Source: European Medicines Agency - EMA (Remove filter) 15 January 2021 INOmax { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Grepid (updated) Source: European Medicines Agency - EMA (Remove filter) 15 January 2021 Grepid { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Lenvima (updated) Source: European Medicines Agency - EMA (Remove filter) 15 January 2021 Lenvima { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Tyverb (updated) Source: European Medicines Agency - EMA (Remove filter) 15 January 2021 Tyverb { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Kisplyx (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Kisplyx { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Zonisamide Mylan (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Zonisamide Mylan { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Zonegran (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Zonegran { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Exelon (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Exelon { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Lixiana (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Lixiana { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Prometax (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Prometax { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Rubraca (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Rubraca { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Mayzent (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Mayzent { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Holoclar (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Holoclar { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Sebivo (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Sebivo { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Neulasta (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Neulasta { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Nexium Control (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Nexium Control { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Valdoxan (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Valdoxan { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Thymanax (updated) Source: European Medicines Agency - EMA (Remove filter) 14 January 2021 Thymanax { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated) Source: European Medicines Agency - EMA (Remove filter) 13 January 2021 Clopidogrel Krka { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Hexyon (updated) Source: European Medicines Agency - EMA (Remove filter) 13 January 2021 Hexyon { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Foclivia (updated) Source: European Medicines Agency - EMA (Remove filter) 13 January 2021 Foclivia { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Fycompa (updated) Source: European Medicines Agency - EMA (Remove filter) 13 January 2021 Fycompa { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Stelara (updated) Source: European Medicines Agency - EMA (Remove filter) 13 January 2021 Stelara { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Phesgo Source: European Medicines Agency - EMA (Remove filter) 13 January 2021 Phesgo { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca Source: European Medicines Agency - EMA (Remove filter) Published by European Medicines Agency, 12 January 2021 The assessment will proceed under an accelerated timeline, and an opinion on the marketing authorisation for use in the EU could be issued by 29 January. Read Summary Type: Medicines Current Awareness (Add filter)
Add this result to my export selection Cyberattack on European Medicines Agency - update Source: European Medicines Agency - EMA (Remove filter) Published by European Medicines Agency, 12 January 2021 Ongoing investigation found some of unlawfully accessed documents related to COVID-19 medicines & vaccines belonging to third parties have been leaked on internet. Regulatory network remain fully... Read Summary Type: Medicines Current Awareness (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Amyvid (updated) Source: European Medicines Agency - EMA (Remove filter) 12 January 2021 Amyvid { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Enbrel (updated) Source: European Medicines Agency - EMA (Remove filter) 12 January 2021 Enbrel { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Comirnaty (updated) Source: European Medicines Agency - EMA (Remove filter) 12 January 2021 Comirnaty { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Orfadin (updated) Source: European Medicines Agency - EMA (Remove filter) 11 January 2021 Orfadin { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Ozempic (updated) Source: European Medicines Agency - EMA (Remove filter) 11 January 2021 Ozempic { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Ocrevus (updated) Source: European Medicines Agency - EMA (Remove filter) 11 January 2021 Ocrevus { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Axumin (updated) Source: European Medicines Agency - EMA (Remove filter) 11 January 2021 Axumin { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Panretin (updated) Source: European Medicines Agency - EMA (Remove filter) 11 January 2021 Panretin { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): BeneFIX (updated) Source: European Medicines Agency - EMA (Remove filter) 11 January 2021 BeneFIX { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Daurismo (updated) Source: European Medicines Agency - EMA (Remove filter) 08 January 2021 Daurismo { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated) Source: European Medicines Agency - EMA (Remove filter) 08 January 2021 Daptomycin Hospira { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Ninlaro (updated) Source: European Medicines Agency - EMA (Remove filter) 08 January 2021 Ninlaro { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Fintepla Source: European Medicines Agency - EMA (Remove filter) 08 January 2021 Fintepla { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Prevenar 13 (updated) Source: European Medicines Agency - EMA (Remove filter) 08 January 2021 Prevenar 13 { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Human medicine European public assessment report (EPAR): Xyrem (updated) Source: European Medicines Agency - EMA (Remove filter) 08 January 2021 Xyrem { "service": "sbkm", "selection": false, "css": { "button": "ema-share-btn" }, "via": "EMA_News" Type: Prescribing and Technical Information (Add filter)